BRC Therapeutics
PrivateLast Round
Series A
Oct 4, 2022
Total Funding Raised
$23M
Company Overview
BRC Therapeutics is a biopharmaceutical company that develops cannabinoid-based prescription medicines for the treatment of pain and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BRC Therapeutics Comparables
Compare BRC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Groff North America | 84% | |
| Maridose LLC | 83% | |
| Royal Emerald Pharmaceuticals | 80% |
BRC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 4, 2022 | ||||
| Convertible Debt | Oct 2, 2020 |
BRC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Achari Ventures | Series A |
| Intrinsic Capital Partners | Series A |
| Delta Emerald Ventures | Series A |
| AFI Capital Partners | Series A |
| Argonautic Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2025
Dr. Stephen Wright joins as Advisor in Drug Development.
- Oct 4, 2022
$20M round led by Intrinsic Capital Partners.
BRC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BRC Therapeutics's valuation, stock price, and market status.
Is Biopharmaceutical Research Company a public or private company?
Biopharmaceutical Research Company is a private company.
What is the current stock price of Biopharmaceutical Research Company?
Biopharmaceutical Research Company is a private company with no public stock price. No recent secondary market data is available.
How much is Biopharmaceutical Research Company worth (valuation)?
Valuation information for Biopharmaceutical Research Company is not publicly available.
Can I buy Biopharmaceutical Research Company stock?
Biopharmaceutical Research Company shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biopharmaceutical Research Company's last funding round?
Biopharmaceutical Research Company's most recent funding round was Series A on October 4, 2022.
Who are the main investors in Biopharmaceutical Research Company?
Key investors in Biopharmaceutical Research Company include Intrinsic Capital Partners.
Will Biopharmaceutical Research Company IPO soon?
No public IPO plans have been announced for Biopharmaceutical Research Company.
How can I track Biopharmaceutical Research Company secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biopharmaceutical Research Company's secondary market activity and sign up for updates.